I am not sure, though, that what you have got in your testimony is entirely accurate because diethylstilbestrol was approved by the Food and Drug Administration in 1947 for the treatment of habitual miscarriage.

And I will tell you the thing that I heard over and over again, the themes that came through loud and clear to me during those summer town halls was, number one, don't disrupt the entire system.

I got to tell you the Environmental Protection Agency, right now the number one problem that your asthmatic patients have today is because of the Environmental Protection Agency, and that is the prevention of the sale of an…

I am confident that this hearing will help us continue making the case that the Obama administration needs to move faster to reduce the regulatory burdens of American companies.

And then the other thing we heard was if you are going to do anything at all, would you please help us with costs?

I get so frustrated when I hear the administration say that this is going to be free and that is going to be free.

I thought it might interest you to know that I spent the evening before we voted on the Affordable Care Act in the Rules Committee and I had a number of amendments that I tried to get made in order.

When you allocate all those costs to the private sector, the businesses that you are looking to to create jobs, you inhibit if you do not eliminate our ability to create jobs.

We have to get it done, and so I appreciate all of you being here...

Don't tell me they don't want to do their job. If a Federal agency doesn't want to do its job, then perhaps we will have that discussion, but this is their job.

It is clearly something that needs your highest attention and I look forward not just to your framework but we actually look forward to some performance on this.

Thank you, Mr. Chairman, and Dr. Shuren, again, thank you for being here. You are going to hear today some concerns from people on the dais and from our subsequent panel, from patients and innovators.